Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)

35RC16_3037_IMPECstudy

Study of immunosuppression biomarkers in patients with ARDS or cardiogenic shock with ECMO / ECLS, compared to patients with ARDS or cardiogenic shock without ECMO / ECLS

2017-01-01

2019-01-31

2019-01-31

Completed

18

Inclusion Criteria: * Patient older than 18 years old * Patient hospitalized in an intensive care unit * Patient whose initial ARDS or Cardiogenic shock began less than 5 days before admission * Patients hospitalized for ARDS or Cardiogenic shock with ECMO / ECLS or - Patients hospitalized for ARDS or Cardiogenic shock without ECMO / ECLS Exclusion Criteria: * Opposition of patient, relative or legal representative for participation in the study * Pregnant woman * Pre-immunodepression * Implementation of immunosuppressive therapy such as chemotherapy, cyclophosphamide, high-dose corticosteroids (\> 0.5mg / kg / day).

{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'bioSpec': {'retention': 'SAMPLES_WITHOUT_DNA', 'description': 'plasma'}, 'enrollmentInfo': {'count': 18, 'type': 'ACTUAL'}}

2023-04-12